A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s171707 ◽

2018 ◽

Vol Volume 13 ◽

pp. 2673-2684 ◽

Cited By ~ 10

Author(s):

Wilfried De Backer ◽

Jan De Backer ◽

Wim Vos ◽

Ilse Verlinden ◽

Cedric Van Holsbeke ◽

...

Keyword(s):

Randomized Study ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects

European Journal of Pharmaceutical Sciences ◽

10.1016/j.ejps.2020.105472 ◽

2020 ◽

Vol 153 ◽

pp. 105472

Author(s):

Samuel Israel ◽

Ashish Kumar ◽

Kiernan DeAngelis ◽

Magnus Aurivillius ◽

Paul Dorinsky ◽

...

Keyword(s):

Dose Inhaler ◽

Metered Dose Inhaler ◽

Healthy Male ◽

Pulmonary Deposition ◽

Metered Dose ◽

Male Subjects ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

Respiratory Research ◽

10.1186/s12931-016-0491-8 ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 14

Author(s):

Colin Reisner ◽

Leonardo M. Fabbri ◽

Edward M. Kerwin ◽

Charles Fogarty ◽

Selwyn Spangenthal ◽

...

Keyword(s):

Fixed Dose ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Metered Dose Inhaler ◽

Obstructive Pulmonary Disease ◽

Metered Dose ◽

Dose Combination ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-Suspension Delivery Technology in Patients with COPD

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3351 ◽

2019 ◽

Author(s):

G.T. Ferguson ◽

K.F. Rabe ◽

E. Bourne ◽

S. Ballal ◽

K. DeAngelis ◽

...

Keyword(s):

Lung Function ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Delivery Technology ◽

Function Assessment ◽

Formoterol Fumarate

Download Full-text

Budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler, formulated using co-suspension delivery technology, improves lung function and exacerbation outcomes in patients with COPD without a recent history of exacerbations: subgroup analysis of KRONOS study

10.1055/s-0039-3403159 ◽

2020 ◽

Author(s):

FJ Martinez ◽

GT Ferguson ◽

E Bourne ◽

S Ballal ◽

P Darken ◽

...

Keyword(s):

Lung Function ◽

Subgroup Analysis ◽

Recent History ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

History Of ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALER, FORMULATED USING CO-SUSPENSION DELIVERY TECHNOLOGY, IMPROVES LUNG FUNCTION AND EXACERBATION OUTCOMES IN PATIENTS WITH COPD WITHOUT A RECENT HISTORY OF EXACERBATIONS: SUBGROUP ANALYSIS OF KRONOS STUDY

CHEST Journal ◽

10.1016/j.chest.2019.08.309 ◽

2019 ◽

Vol 156 (4) ◽

pp. A2276-A2277

Author(s):

Fernando Martinez ◽

Gary Ferguson ◽

Eric Bourne ◽

Shaila Ballal ◽

Patrick Darken ◽

...

Keyword(s):

Lung Function ◽

Subgroup Analysis ◽

Recent History ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

History Of ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

Randomized study of the effects of Aerochamber Plus ® Flow-Vu ® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease

Respiratory Medicine ◽

10.1016/j.rmed.2018.03.033 ◽

2018 ◽

Vol 138 ◽

pp. 74-80 ◽

Cited By ~ 8

Author(s):

Faisal Fakih ◽

Selwyn Spangenthal ◽

Barry Sigal ◽

Patrick Darken ◽

Andrea Maes ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Randomized Study ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Obstructive Pulmonary Disease ◽

Metered Dose ◽

Formoterol Fumarate

Download Full-text

Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

Respiratory Research ◽

10.1186/s12931-017-0638-2 ◽

2017 ◽

Vol 18 (1) ◽

Author(s):

Colin Reisner ◽

Leonardo M. Fabbri ◽

Edward M. Kerwin ◽

Charles Fogarty ◽

Selwyn Spangenthal ◽

...

Keyword(s):

Fixed Dose ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Metered Dose Inhaler ◽

Obstructive Pulmonary Disease ◽

Metered Dose ◽

Dose Combination ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology

Pulmonary Pharmacology & Therapeutics ◽

10.1016/j.pupt.2018.01.007 ◽

2018 ◽

Vol 49 ◽

pp. 67-74 ◽

Cited By ~ 3

Author(s):

Gary T. Ferguson ◽

Colin Reisner ◽

James Pearle ◽

Paolo DePetrillo ◽

Andrea Maes ◽

...

Keyword(s):

Safety Profile ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Inhaler ◽

Cardiovascular Safety ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Dose Combination ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s220850 ◽

2019 ◽

Vol Volume 14 ◽

pp. 2979-2991 ◽

Cited By ~ 1

Author(s):

Masakazu Ichinose ◽

Yasushi Fukushima ◽

Yoshikazu Inoue ◽

Osamu Hataji ◽

Gary T Ferguson ◽

...

Keyword(s):

Subgroup Analysis ◽

Japanese Patients ◽

Dose Inhaler ◽

Efficacy And Safety ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol

Respiratory Medicine ◽

10.1016/j.rmed.2019.08.010 ◽

2019 ◽

Vol 158 ◽

pp. 59-66 ◽

Cited By ~ 8

Author(s):

Klaus F. Rabe ◽

Fernando J. Martinez ◽

Gary T. Ferguson ◽

Chen Wang ◽

Dave Singh ◽

...

Keyword(s):

Triple Therapy ◽

Study Protocol ◽

Phase Iii ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Phase Iii Study ◽

Delivery Technology ◽

Severe Copd ◽

Formoterol Fumarate

Download Full-text

A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD

Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-Suspension Delivery Technology in Patients with COPD

Budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler, formulated using co-suspension delivery technology, improves lung function and exacerbation outcomes in patients with COPD without a recent history of exacerbations: subgroup analysis of KRONOS study

BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALER, FORMULATED USING CO-SUSPENSION DELIVERY TECHNOLOGY, IMPROVES LUNG FUNCTION AND EXACERBATION OUTCOMES IN PATIENTS WITH COPD WITHOUT A RECENT HISTORY OF EXACERBATIONS: SUBGROUP ANALYSIS OF KRONOS STUDY

Randomized study of the effects of Aerochamber Plus ® Flow-Vu ® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease

Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study

A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol

A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol